|
|
||||||||
1-antitrypsin deficiency
Departments of Pulmonary and Critical Care Medicine and Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195
Quantitations of exhaled
nitric oxide (NO) and carbon monoxide (CO) have been proposed as
noninvasive markers of airway inflammation. We hypothesized that
exhaled CO is increased in individuals with
1-antitrypsin (AT) deficiency, who have lung
inflammation and injury related to oxidative and proteolytic processes.
Nineteen individuals with
1-AT deficiency, 22 healthy
controls, and 12 patients with non-
1-AT-deficient
chronic obstructive pulmonary disease (COPD) had NO, CO,
CO2, and O2 measured in exhaled breath. Individuals with
1-AT deficiency had lower levels of NO
and CO than control or COPD individuals.
1-AT-deficient
and COPD patients had lower exhaled CO2 than controls,
although only
1-AT-deficient patients had higher exhaled
O2 than healthy controls. NO was correlated inversely with
exhaled O2 and directly with exhaled CO2,
supporting a role for NO in regulation of gas exchange. Exhaled gases
were not significantly related to corticosteroid use or lung function. Demonstration of lower than normal CO and NO levels may be useful as an
additional noninvasive method to evaluate
1-AT
deficiency in individuals with a severe, early onset of obstructive
lung disease.
airway inflammation; chronic obstructive pulmonary disease
This article has been cited by other articles:
![]() |
R. F. Machado, D. Laskowski, O. Deffenderfer, T. Burch, S. Zheng, P. J. Mazzone, T. Mekhail, C. Jennings, J. K. Stoller, J. Pyle, et al. Detection of Lung Cancer by Sensor Array Analyses of Exhaled Breath Am. J. Respir. Crit. Care Med., June 1, 2005; 171(11): 1286 - 1291. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |